PROCESS FOR MAKING BLOCK POLYMERS OR COPOLYMERS FROM ISOTACTIC POLYPROPYLENE

Details for Australian Patent Application No. 2003270488 (hide)

Owner DONEY, Grant, W.

Inventors SALSMAN, Keith; DONEY, Grant, W.

Pub. Number AU-A-2003270488

PCT Number PCT/US03/28328

PCT Pub. Number WO2004/041885

Priority 10/285,268 31.10.02 US

Filing date 9 September 2003

Wipo publication date 7 June 2004

International Classifications

C08F 251/00 Graft polymers

C08F 265/02 Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group

C08F 255/02 Macromolecular compounds obtained by polymerising monomers on to polymers of hydrocarbons as defined in group

C08F 283/08 Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass

C08F 293/00 Block polymers

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 10/285,268 31.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2003270488

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003270489-6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-Y LAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF

2003270487-USE OF STATINS IN THE PREVENTION AND TREATMENT OF RADIATION INJURY AND OTHER DISORDERS ASSOCIATED WITH REDUCED ENDOTHELIAL THROMBOMODULIN